Scientific article

Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome

Published inJournal of Immunology, vol. 205, no. 4, p. 1167-1175
Publication date2020

IL-18 binding protein (IL-18BP) acts as a naturally occurring IL-18 decoy receptor. If the balance between IL-18 and IL-18BP is dysregulated, abnormal levels of free bioactive IL-18 are detected, such as in the sera of Il-18bp knockout (KO) mice with CpG-induced macrophage activation syndrome. To determine the cellular sources of Il-18bp in vivo, we selectively depleted Il-18bp expression in either radiosensitive or radioresistant cells using bone marrow transfer between wild-type (WT) and Il-18bp KO mice. Following repeated CpG injections, Il-18bp KO (donor)→ Il-18bp KO (recipient) chimeric mice exhibited more severe disease, with an enhanced Ifn-γ signature and circulating free Il-18 levels, in comparison with WT→WT chimeras. Interestingly, the phenotype of KO→WT and WT→KO mice did not differ from that of WT→WT mice. Consistent with this finding, serum Il-18bp levels were similar in these three groups of mice. The contribution of radioresistant and radiosensitive cells to Il-18bp production varied markedly according to the organ examined, with a major contribution of radiosensitive cells in the spleen as opposed to a major contribution of radioresistant cells in the lung. Finally, Ifn-γ blockade abrogated the CpG-induced but not the constitutive Il-18bp production. Our results demonstrate that circulating Il-18bp is induced in response to Ifn-γ during CpG-induced macrophage activation syndrome and is present at high levels in the circulation to prevent the deleterious systemic effects of Il-18.

  • Swiss National Science Foundation - 310030_712674
  • Autre - Institute of Rheumatology Research, and the Rheumasearch Foundation
Citation (ISO format)
HAREL, Mathilde Alexia Rolande et al. Production of IL-18 Binding Protein by Radiosensitive and Radioresistant Cells in CpG-Induced Macrophage Activation Syndrome. In: Journal of Immunology, 2020, vol. 205, n° 4, p. 1167–1175. doi: 10.4049/jimmunol.2000168
Main files (1)
Article (Published version)
ISSN of the journal0022-1767

Technical informations

Creation10/09/2020 6:34:00 PM
First validation10/09/2020 6:34:00 PM
Update time03/15/2023 11:19:16 PM
Status update03/15/2023 11:19:15 PM
Last indexation10/19/2023 1:58:58 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack